Professor Dr Darren Creek is an ARC Future Fellow and Director of the Drug Target Identification node of the Monash Proteomics and Metabolomics Platform. He completed his Bachelor of Pharmacy and PhD at Monash University in 2007, followed by postdoctoral fellowships in biochemical parasitology at the University of Glasgow and the University of Melbourne, as well as a clinical pharmacokinetics study in Uganda in collaboration with UCSF-Makerere University.

 

Over the past decade, his laboratory at the Monash Institute of Pharmaceutical Sciences has made significant contributions to malaria drug discovery and parasite metabolism, while developing new analytical tools for metabolomics and proteomics. His work is described across 175 publications. He is also Co-coordinator for the MIPS Global Health Therapeutic Programme Area and currently leads a research team focused on discovering new drug candidates for malaria.

Emeritus Professor Dr Roger Phillips is a cancer pharmacologist specialising in tumour hypoxia and the development of novel anti-cancer agents through both target-oriented and phenotype-based discovery approaches. His research has achieved significant clinical relevance, most notably through the development of Apaziquone (EO9) for non-muscle invasive bladder cancer, which progressed to Phase II clinical trials in the USA, Canada, and Europe.

 

He has published more than 150 research articles and supervised over 30 postgraduate students. His teaching is strongly research-led, with a focus on bringing the latest advances in cancer pharmacology into the classroom. Although he retired as Associate Dean for Research at the University of Huddersfield in September 2024, he remains research active as Professor Emeritus. He also holds an Adjunct Professorship at Taylor's University, Malaysia.

Associate Professor Dr Chalermpong Saenjum is an academic at Chiang Mai University, Thailand, where he earned his Bachelor's, Master's, and PhD degrees in Pharmacy. His doctoral studies were supported by the Franco-Thai Scholarship Programme in collaboration with the University of Paris 6, France. He currently serves as Associate Professor in the Department of Pharmaceutical Sciences and Head of the Research Centre for Innovation in Analytical Science and Technology for Biodiversity-Based Economy and Society (I-ANALY-S.T.BES-CMU) at Chiang Mai University's Multidisciplinary Research Institute.

 

His research focuses on green and sustainable chemical and pharmaceutical analysis, including scaled-down methods, simplified procedures, and the use of natural reagents and solvents. He is also involved in the discovery and development of natural product active pharmaceutical ingredients and their molecular signalling pathways. He has published over 135 peer-reviewed international papers, with approximately 1,750 citations and an H-index of 22.

Associate Professor Dr Ernieda Binti Md Hatah is a clinical pharmacy specialist whose research centres on pharmaceutical policy, medication adherence, and pharmacy service development to improve the quality use of medicines. Her work contributes to evidence-based approaches in healthcare practice and informs ongoing improvements in pharmacy service delivery in Malaysia.

Associate Professor Dr Jason Loo holds an MPharm from the University of Strathclyde and a PhD from the University of Nottingham, completed in 2015. He is currently Associate Professor and Programme Director of the Bachelor of Pharmacy with Honours programme at Taylor's University, and serves as a Council Member of the Malaysian Academy of Pharmacy.

 

His research specialises in computational drug design, with a focus on biomolecular simulations of protein-ligand systems and free energy calculations using methods such as metadynamics and alchemical perturbation. His work spans G protein-coupled receptors and cancer-related targets including Golgi alpha-mannosidase II and the cell surface marker Ly6D. He has published over 30 journal articles in high-impact journals and secured more than half a million ringgit in research funding.

Associate Professor Dr Margarita "Meg" M. Gutierrez is a tenured Associate Professor at the University of the Philippines Manila College of Pharmacy, where she serves as Chair of the Department of Clinical, Social and Administrative Pharmacy. She holds a Bachelor of Science in Industrial Pharmacy and a Master of Health Professions Education from UP Manila, and a PhD in Social and Administrative Pharmacy from Chulalongkorn University, Thailand. She is currently pursuing a second PhD in Health Professions Education at UP Manila. A former president of the Philippines Young Pharmacists Group, she is also a Founder Fellow of the Philippine chapter of the FAPA College of Pharmacy.

 

Her contributions to pharmacy education have earned her international recognition, including the FIP Ton Hoek Scholarship for Young Leaders (2019), the FAPA Outstanding Young Pharmacist Award (2024), and the PPhA Most Outstanding Pharmacist in the Academe Award (2024).

Associate Professor Dr Renukha Sellappans is Head of the School of Pharmacy at Taylor's University, Malaysia, and Organising Chairperson of the 5th ASEAN PharmNET 2026 Conference. A trained clinical pharmacist, she practised in a hospital setting before completing her PhD at the University of Malaya. She is a Board Certified Pharmacotherapy Specialist (2018–2025), serves as Principal of the Malaysian Academy of Pharmacy, and is a Board Member of the Pharmacy Board of Malaysia.

 

Her research interests include pharmacy practice, medication use, and patient safety among older persons. She brings extensive academic, clinical, and leadership experience to her commitment to advancing pharmacy education, research, and professional excellence in Malaysia.

Associate Professor Dr Steven Lim Siong Meng is a pharmacy academic and cancer researcher at Universiti Teknologi MARA (UiTM), Malaysia. He obtained his PhD in Medicine from the University of New South Wales, Australia, in 2013 and has served as Associate Professor in UiTM's Department of Pharmacology and Life Sciences since 2019, where he also co-leads the Collaborative Drug Discovery Research Group. His research spans tumour angiogenesis, drug discovery, nutraceuticals, functional foods, anticancer and neuroprotective agents, and therapeutic target identification for cancer, Alzheimer's disease, and Parkinson's disease.

 

He has published 130 indexed journal articles and five book chapters, supervised 11 PhD and 11 Master's graduates, and secured international, national, and industry research grants totalling RM6.1 million. He is active in the Malaysian Association for Cancer Research and the Malaysian Society of Lactic Acid Bacteria.

Associate Professor Dr Surakit Nathisuwan is Associate Professor in Clinical Pharmacy and Dean of the Faculty of Pharmacy at Mahidol University, Thailand, and serves as Secretariat of the ASEAN PharmNET network. His teaching and research specialise in cardiovascular pharmacotherapy, and he has worked actively with professional organisations and government bodies to advance the competency of Thai pharmacists in patient-oriented care for cardiovascular disease.

 

He has contributed in various capacities to national and international organisations in the areas of drug policy, health systems, and the advancement of pharmacy education and practice.

Associate Professor Dr Usa Chaikledkaew holds a Bachelor of Pharmacy with First Class Honours from Mahidol University, a Master's degree in Economics, and a PhD in Pharmaceutical Economics and Policy from the University of Southern California. She currently serves as Director of the Global Health Technology Assessment (GHTA) Research Centre and Co-Programme Director of the Mahidol University Health Technology Assessment (MUHTA) Graduate Programme. She was a research consultant and founding member of the Health Intervention and Technology Assessment Programme (HITAP), and has served on the health economics working group for the National List of Essential Medicines and as an editor of Thailand's first and second Health Technology Assessment guidelines.

 

Her research in health economics has been widely published in international peer-reviewed journals and has informed policy decisions on national pharmaceutical reimbursement and Universal Health Coverage benefit packages in Thailand and other low- and middle-income countries.

Dr Fun Weng Hong is Head of the Centre for Health Outcomes Research at the Institute for Health Systems Research, Ministry of Health Malaysia. His work spans health economics, health outcomes, and health systems research, including the use of modelling to inform policy and service planning. He previously served as Cluster Head for the Aged Population under the MOH Research Grant and was a member of the Health Technology Assessment Technical Advisory Committee.

 

His research areas include healthy ageing, long-term care, health system performance, and cancer screening, with outputs that support policy planning and decision-making within the Malaysian health system. He also serves as Adjunct Lecturer at Monash University Malaysia.

Dr Koh Hock Peng is a pharmacist with over 15 years of professional experience spanning clinical practice and academia. He holds a PhD in Pharmaceutical Sciences, a Master of Clinical Pharmacy, and a Bachelor of Pharmacy with Honours. He currently practises as a Clinical Emergency Medicine Pharmacist at Hospital Kuala Lumpur and serves as Chairperson of the national working committee on clinical emergency pharmacy, contributing to the advancement of emergency pharmacy services in Malaysia.

 

His clinical work focuses on emergency and cardiology care, and he has over 20 publications to his name, alongside multiple awards for research presentations including the Young Investigator Award. He has also contributed to the development of several national clinical guidelines.

Professor Dr Arry Yanuar is Professor of Medicinal Chemistry at the Faculty of Pharmacy, Universitas Indonesia, where he leads the Biomedical Computation and Drug Design Laboratory. He holds a Bachelor of Science in Pharmacy from Universitas Indonesia, a Master's degree in Pharmaceutical Chemistry from Gadjah Mada University, and a PhD in Structural Biology from the Nara Institute of Science and Technology (NAIST), Japan (2006). His expertise encompasses computer-aided drug design and artificial intelligence, including QSAR, virtual screening, molecular docking, and molecular dynamics simulations.

 

He has published over 170 scientific works, including 88 journal articles and 13 conference papers indexed in Scopus, as well as 87 publications in Web of Science, two books, and one book chapter. Since his appointment as Professor in 2019, he has supervised 9 PhD, 24 Master's, and 134 undergraduate students.

Professor Dr Chonlaphat Sukasem is a leading expert in clinical pharmacogenomics and personalised medicine at Mahidol University, Thailand. He serves as Professor in Clinical Pathology and Pharmacogenomics, Head of the Division of Pharmacogenomics and Personalised Medicine, and Chief of the Laboratory for Pharmacogenomics at Somdech Phra Debaratana Medical Centre. A pioneer in Asian clinical pharmacogenomics, he was the first Project Manager of the Pharmacogenomics Thailand Project (2004) and is a founding member and Secretariat of the Southeast Asian Pharmacogenomics Association (SEAPHARM). He also holds an appointment as Senior Lecturer in Molecular and Clinical Pharmacology at the University of Liverpool.

 

With over 200 peer-reviewed publications, his research focuses on pharmacogenomics, clinical pharmacology, drug safety, and precision medicine, including the discovery of biomarkers for severe cutaneous adverse drug reactions and the translation of pharmacogenetic testing into clinical practice.

Professor Dr Giorgia Pastorin is Head of the Department of Pharmacy and Pharmaceutical Sciences at the National University of Singapore (NUS). She earned her PhD in Pharmaceutical Chemistry from the University of Trieste, Italy, in 2004, followed by a research fellowship at CNRS in France. She joined NUS as Assistant Professor in 2005, was promoted to Associate Professor in 2011, appointed Assistant Dean for Research and Development in 2017, and attained Full Professor in 2024.

 

Her research focuses on the production, characterisation, and evaluation of cell-derived nanovesicles and biohybrid systems as biocompatible nanocarriers for delivering bioactive molecules, including anti-cancer drugs and cosmetic compounds. She has secured more than S$15 million in competitive grants as lead principal investigator, edited two books, and authored approximately 170 peer-reviewed articles with over 15,000 citations. She is internationally recognised through invited lectures, keynote presentations, and awards for her BioNano-technology group's contributions to the field.

Professor Dr Hasniza Zaman Huri is Deputy Vice Chancellor (Academic and International) at Universiti Malaya. As founding Dean of the Faculty of Pharmacy (2019–2025), she led the faculty to its first global ranking, placing 72nd worldwide in Pharmacy and Pharmacology in the QS 2024 rankings. She also serves as Honorary Visiting Consultant at the Clinical Investigation Centre, University Malaya Medical Centre. Beyond her institutional roles, she sits on the Drug Control Authority under the Ministry of Health Malaysia and represents Malaysia in the Global Alliance for the Development of Pharmaceutical Science. She contributes as a Key Opinion Leader in regional clinical trial policy initiatives across ASEAN.

 

Her sustained leadership and contributions to pharmacy practice, education, and professional advancement have been recognised with the World Class Professor Award (2022), the Malaysian Pharmacists Society Outstanding Leadership Award (2024), and the Fellowship of the Malaysian Pharmacists Society (FMPS) in 2026.

Professor Dr Mohd Cairul Iqbal bin Mohd Amin is a distinguished academic in Pharmaceutics at Universiti Kebangsaan Malaysia, where he has served since 1997. He holds a Bachelor of Pharmacy and PhD from the University of Manchester, United Kingdom, and has served as Visiting Professor and Visiting Scholar in Thailand, Indonesia, and other countries. He has held key leadership roles including Deputy Director at the Department of Higher Education (2019–2021) and multiple Deputy Dean positions covering postgraduate studies, innovation, undergraduate affairs, alumni relations, and international engagement.

 

His research focuses on advanced drug delivery systems, including hydrogels, bacterial cellulose-based carriers, and nano-delivery platforms. He has published over 100 high-impact papers, supervised 35 postgraduate students, and secured nearly RM14 million in research grants. He founded the Malaysian chapter of the Controlled Release Society, promoting controlled-release technologies locally and internationally.

Professor Dr Mohd bin Makmor Bakry is Dean of the Faculty of Pharmacy at Universiti Kebangsaan Malaysia (UKM). He holds a Bachelor of Pharmacy from UKM, a Master of Clinical Pharmacy from Universiti Sains Malaysia, and a PhD from the University of Glasgow, Scotland, where he also completed an epilepsy research fellowship at Western Infirmary Glasgow. He is the recipient of the Malaysian National Academic Award 2017 in Health Sciences, the Malaysian Higher Education Rethinking and Redesigning Award 2017, and the Malaysian Pharmacists Society Outstanding Pharmacist Award 2024.

 

He has published over 150 journal articles and delivered more than 60 invited talks as keynote, plenary, and invited speaker at local and international conferences. He serves on national committees including the Drug Control Authority and the Pharmacy Board of Malaysia, and at the international level as Board Member of the Association of Asian Schools of Pharmacy and the US-ASEAN Pharmacy Consortium.

Emeritus Professor Dr Paraidathathu Thomas is a pharmacy academic, educator, and regulatory affairs expert with a distinguished career spanning hospital practice, drug regulation, and higher education. He holds a Bachelor of Pharmacy from Mangalore University, and MSc and PhD degrees in Pharmacology and Toxicology from the University of Texas at Austin. He began his career as a hospital pharmacist before becoming one of the pioneers of drug regulatory affairs in Malaysia between 1985 and 1996. He subsequently joined Universiti Kebangsaan Malaysia, where he served for 16 years and was conferred the title of Emeritus Professor in 2016. He later served as Dean of the School of Pharmacy at Taylor's University.

 

He has contributed to pharmacy education accreditation and evaluation panels internationally, and is the author of Pharmacy in Malaysia: History and Development (2018).

Professor Dr Paul J. Gallagher is Professor of Pharmacy at the Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, with over 30 years of experience spanning clinical practice, academic leadership, and international policy. He chairs the FIP–UNESCO–UNITWIN Centre for Excellence for the Western Pacific Region, serves as Board Member of the US-ASEAN Pharmacy Consortium, and is a Member of the Asian Association of Schools of Pharmacy. His research focuses on pharmacist-led collaborative care models, medication adherence, and patient safety, with studies demonstrating improved outcomes in diabetes and cardiometabolic disease. He is co-developer of the widely cited POSAMINO criteria for alcohol-medicine interactions in older adults.

 

He has led the design and implementation of integrated pharmacy programmes in Ireland and Singapore, contributed to national continuing professional development systems, and is a long-standing contributor to the International Pharmaceutical Federation.

Professor Dr Pornsak Sriamornsak is Dean of the Faculty of Pharmacy at Silpakorn University, Thailand, and a distinguished leader in pharmaceutical sciences. He previously served as Vice President for Academic Affairs and Research (2017–2019) and has played a significant role in advancing pharmacy education and research in Thailand. He holds pharmacy degrees from Mahidol University (Thailand) and a PhD from Charles Sturt University (Australia). He serves as President of the Council of Pharmacy Deans of Thailand and holds leadership roles in regional organisations, including President of the Asian Association of Environmental Mutagen Societies and Vice President of the Asian Federation for Pharmaceutical Sciences.

 

His research focuses on drug delivery systems, biopolymers, and pharmaceutical technologies, with over 250 publications. He has received numerous international awards and has been consistently ranked among Stanford University's World's Top 2% of Scientists.

Professor Dr Triana Hertiani is Professor of Pharmaceutical Biology at Universitas Gadjah Mada and currently serves as Rector of Universitas Jenderal Achmad Yani Yogyakarta, Indonesia. Her research focuses on developing natural product-based therapies derived from Indonesia's biodiversity, particularly for anti-infective applications, as well as evidence-based herbal medicine. She integrates phytochemistry, metabolomics, and network pharmacology to support the translation of bioactive compounds into clinically relevant candidates, including through sustainable development approaches.

 

She has contributed to over 100 peer-reviewed publications in international journals and holds several patents in natural product research. She actively collaborates with academic, industry, and government partners to advance natural product research into impactful health solutions.

Professor Dr Wong Tin Wui is a lecturer and principal fellow at Universiti Teknologi MARA's Faculty of Pharmacy and Smart Manufacturing Research Institute. His research focuses on precision nanodrug delivery via oral, dermal, and pulmonary routes, supporting advances in pharmaceutical formulation and targeted therapy. He has published over 185 peer-reviewed articles and serves on editorial boards for several international journals, including the Asian Journal of Pharmaceutical Sciences, Drug Development and Industrial Pharmacy, and Frontiers in Pharmacology. He founded Malaysia's Non-Destructive Biomedical and Pharmaceutical Research Centre and the Sino-Malaysia Molecular Oncology and Traditional Chinese Medicine Delivery Joint Research Centre in China.

 

He has held visiting, adjunct, and lecture professorships across Malaysia, Singapore, China, India, and Thailand, is a Fellow of the Academy of Sciences Malaysia, and received the FAPA Scientific Section Award in 2023.